NIACOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Niacor, and what generic alternatives are available?
Niacor is a drug marketed by Avondale Pharms and is included in one NDA.
The generic ingredient in NIACOR is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Niacor
A generic version of NIACOR was approved as niacin by BARR on April 14th, 2005.
Summary for NIACOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 212 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,148 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NIACOR at DailyMed |
Recent Clinical Trials for NIACOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Pennsylvania | N/A |
| Heidelberg University | Phase 1 |
Pharmacology for NIACOR
| Drug Class | Nicotinic Acid |
US Patents and Regulatory Information for NIACOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avondale Pharms | NIACOR | niacin | TABLET;ORAL | 040378-001 | May 3, 2000 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
